Code
01D36611
Duration
01 October 2011 → 30 September 2015
Funding
Regional and community funding: Special Research Fund
Promotor
Research disciplines
-
Natural sciences
- Organic chemistry
-
Medical and health sciences
- Biomarker discovery and evaluation
- Drug discovery and development
- Medicinal products
- Pharmaceutics
- Pharmacognosy and phytochemistry
- Pharmacology
- Pharmacotherapy
- Toxicology and toxinology
- Other pharmaceutical sciences
Keywords
synthesis
KRN 7000
NKT cells
Project description
Synthesis of sugar and sphingosine modified alpha-galactosylceramide (KRN 7000) analogues as NKT cell agonists capable of inducing a Th1-polarised cytokine response. The proposed modifications intend to establish an improved binding affinity to the antigenpresenting CD1d protein, which should result in a bias towards a Th1 respons, as well as an improved aqueous solubility.